We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AACC 2023 Celebrates 75 Years of Innovation and Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 18 Jul 2023

The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo is showcasing breakthrough innovations shaping the future of clinical testing and patient care. More...

The world's largest exhibition for in vitro diagnostics is hosted every year by the American Association for Clinical Chemistry (Washington, DC, USA).  AACC 2023 is being held from July 23-27 at the Anaheim Convention Center in California, where laboratory medicine experts are presenting cutting-edge research and technology.

Attendees can benefit from a stunning lineup of expert speakers and scientific sessions, as well as view a vast array of emerging technologies and products at the premier global laboratory medicine exposition. The AACC Clinical Lab Expo offers attendees the opportunity to browse more than 900 exhibitors across over 200 product categories in person for solutions to their lab-related needs. They can connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other fields of breaking science in laboratory medicine. Attendees can also hear vital research and learn about important changes in the field. With over 250 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, they can design an educational experience that fulfills their need to keep ahead of the changes in their field.

At AACC 2023, attendees can visit the electronic billboard outside the Expo Hall entrance to learn about innovative new products and services. They have the opportunity to interact with the product showcase to obtain detailed product and service information. Attendees can also learn about the latest diagnostic technologies and services in 20-minute lecture series presentations at the theater conveniently located in the exhibit hall without the need to leave the action of the Expo. At the exhibit hall theaters, attendees can learn about new diagnostic breakthroughs and significant developments in laboratory medicine. Industry workshops are also being offered in nearby hotels. Posters of accepted abstracts are on display in the Poster Hall on the Expo Show floor for both scientific conference and expo hall attendees to visit.

This year, the AACC Clinical Lab Expo is providing additional opportunities to network with colleagues and make new connections. The Clinical Lab Expo Happy Hour is back this year where attendees can mix and mingle and will receive one complimentary drink ticket. They can also enjoy an afternoon break on the expo floor with light refreshments to recharge and connect with fellow attendees and exhibitors. This year, AACC is once again hosting its popular annual Laboratory Feud – a special game show-style event. The two teams, Faculty vs. Fellows, will compete by continuing the celebration of AACC’s 75th anniversary with coverage in different areas of laboratory medicine including history, nutrition, pre-analytical errors, testing methods, immunology, point-of-care testing, TDM and toxicology, among others. To remind everyone of all the innovations the field has seen in the past 75 years, the feud will end with a fast money/lightning round that focuses exclusively on AACC history trivia.

Related Links:
American Association for Clinical Chemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Automatic CLIA Analyzer
Shine i6000
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.